Site icon OncologyTube

HER2+ NSCLC: When to Introduce Targeted Therapies – 2022 Program: Targeted Therapies Forum

Targeted Therapies Forum 2022, Breakout Session: In this video, Drs. Calvo and Thompson discuss when to use targeted therapy in HER2+ disease, and possible upcoming trials.

We thank our sponsors for this year’s support! #Novartis #Janssen #Blueprintmedicine #TakedaOncology #Astrazeneca #LillyOncology #genentech

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.

Exit mobile version